Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析

◆英語タイトル:Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15778
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥56,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Alkermes Plc (ALKS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-release intramuscular injectable suspension for the treatment of schizophrenia; and Vivitrol, a once-monthly, non-addictive, injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence. It also grants license under its proprietary technologies to enable third parties to develop, commercialize and manufacture products. Alkermes sells its products primarily to wholesalers, specialty distributors and specialty pharmacies. The company also has a clinical pipeline of products that address CNS disorders such as multiple sclerosis, schizophrenia, depression and addiction. Alkermes is headquartered in Dublin, Ireland.

Alkermes Plc Key Recent Developments

Mar 22,2019 Alkermes Statement on National Academies of Sciences, Engineering, and Medicine Report on Medications for Opioid Use Disorder
Feb 14,2019 Alkermes Reports Financial Results for the Year Ended Dec. 31, 2018 and Provides Financial Expectations for 2019
Jan 16,2019 Alkermes announces recipients of 1st annual ALKERMES PATHWAYS RESEARCH AWARDS (SM) Program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Alkermes Plc – Key Facts
Alkermes Plc – Key Employees
Alkermes Plc – Key Employee Biographies
Alkermes Plc – Major Products and Services
Alkermes Plc – History
Alkermes Plc – Company Statement
Alkermes Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Alkermes Plc – Business Description
Geographical Segment: Ireland
Performance
Geographical Segment: Rest of world
Performance
Geographical Segment: US
Performance
R&D Overview
Alkermes Plc – Corporate Strategy
Alkermes Plc – SWOT Analysis
SWOT Analysis – Overview
Alkermes Plc – Strengths
Alkermes Plc – Weaknesses
Alkermes Plc – Opportunities
Alkermes Plc – Threats
Alkermes Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Alkermes Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 22, 2019: Alkermes Statement on National Academies of Sciences, Engineering, and Medicine Report on Medications for Opioid Use Disorder
Feb 14, 2019: Alkermes Reports Financial Results for the Year Ended Dec. 31, 2018 and Provides Financial Expectations for 2019
Jan 16, 2019: Alkermes announces recipients of 1st annual ALKERMES PATHWAYS RESEARCH AWARDS (SM) Program
Nov 30, 2018: Statement by Richard Pops, Chairman and CEO of Alkermes on the annual CDC report on Drug Overdose deaths and suicide mortality in the United States
Nov 29, 2018: Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia
Oct 29, 2018: Alkermes Announces Publication of Phase 3 Data for ALKS 5461 for Adjunctive Treatment of Major Depressive Disorder in Molecular Psychiatry
Oct 26, 2018: Alkermes announces recipients of 3rd Annual ALKERMES INSPIRATION GRANTS
Oct 26, 2018: Alkermes announces recipients of 3rd Annual ALKERMES INSPIRATION GRANTS
Oct 23, 2018: Alkermes announces third quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Alkermes Plc, Key Facts
Alkermes Plc, Key Employees
Alkermes Plc, Key Employee Biographies
Alkermes Plc, Major Products and Services
Alkermes Plc, History
Alkermes Plc, Other Locations
Alkermes Plc, Subsidiaries
Alkermes Plc, Key Competitors
Alkermes Plc, Ratios based on current share price
Alkermes Plc, Annual Ratios
Alkermes Plc, Annual Ratios (Cont...1)
Alkermes Plc, Annual Ratios (Cont...2)
Alkermes Plc, Interim Ratios
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Alkermes Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Alkermes Plc, Performance Chart (2014 - 2018)
Alkermes Plc, Ratio Charts
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Alkermes Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsui Fudosan Co., Ltd.:戦略・SWOT・企業財務分析
    Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ashmore Group Plc:企業の戦略・SWOT・財務情報
    Ashmore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ashmore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Intuitive Surgical, Inc.:企業の戦略・SWOT・財務情報
    Intuitive Surgical, Inc. - Strategy, SWOT and Corporate Finance Report Summary Intuitive Surgical, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Commonwealth Scientific and Industrial Research Organisation:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Asahi Kasei Corp (3407):製薬・医療:M&Aディール及び事業提携情報
    Summary Asahi Kasei Corp (Asahi Kasei), manufactures, and markets chemical products. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation panels, foundation systems, methyl methacrylate, adipic acid, polyethylene, polystyrene, functiona …
  • Pvi Holdings:企業の戦略・SWOT・財務分析
    Pvi Holdings - Strategy, SWOT and Corporate Finance Report Summary Pvi Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Norzinc Ltd:企業の戦略・SWOT・財務分析
    Norzinc Ltd - Strategy, SWOT and Corporate Finance Report Summary Norzinc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Adenovir Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Adenovir Pharma AB (Adenovir Pharma) focuses on the development of antiviral pharmaceutical solutions for the treatment of infectious eye diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis (EKC). The company’s APD-209 is topical pharmaceutical product that prevents …
  • KCOM Group PLC (KCOM):企業の財務・戦略的SWOT分析
    Summary KCOM Group PLC (KCOM) is a technology company that provides communication and information technology services. The company provides IT and integration services, including cloud-based infrastructure and contact and collaboration solutions. It offers broadband and telephony services for consum …
  • Welspun Corp Ltd:企業の戦略・SWOT・財務情報
    Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Polyplex (Thailand) Public Company Limited:企業の戦略・SWOT・財務分析
    Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • The Bank of Kochi, Ltd.:企業の戦略・SWOT・財務情報
    The Bank of Kochi, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Bank of Kochi, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bulova Technologies Group, Inc.:戦略・SWOT・企業財務分析
    Bulova Technologies Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bulova Technologies Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Velesto Energy Bhd (UMWOG):企業の財務・戦略的SWOT分析
    Summary Velesto Energy Bhd (Velesto) formerly UMW Oil & Gas Corp Bhd, is an oilfield service provider. It serves customers in upstream sector of the oil and gas industry. The company owns and operates offshore drilling rigs and modular and versatile workover units. Its oilfield service offerings inc …
  • H.I.G. Capital LLC:企業の戦略的SWOT分析
    H.I.G. Capital LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Anadarko Petroleum Corp (APC):石油・ガス:M&Aディール及び事業提携情報
    Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, and natural gas liquids (NGLs) from its assets. It also involves in gathering, processing, treating, …
  • GGP Inc:戦略・SWOT・企業財務分析
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務分析
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆